Coprosterol

Coprosterol is a lipid of Sterol Lipids (ST) class. Coprosterol is associated with abnormalities such as Cerebrovascular accident, Glycogen Storage Disease Type IV, Coronary Arteriosclerosis, CARDIAC EVENT and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as cholesterol absorption, Death, Sudden, Cardiac, Drug Interactions, Cholesterol Homeostasis and Synthesis. Coprosterol often locates in lipid raft, Tissue membrane, Membrane, Blood and Body tissue. The associated genes with Coprosterol are ABO gene, STN gene, Alleles, Apolipoprotein E gene and TNF gene. The related lipids are saturated fat, campesterol, lathosterol, Sterols and Total cholesterol. The related experimental models are Rodent Model.

Cross Reference

Introduction

To understand associated biological information of Coprosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Coprosterol?

Coprosterol is suspected in Coronary Arteriosclerosis, Cerebrovascular accident, Glycogen Storage Disease Type IV, CARDIAC EVENT, Diabetes Mellitus, Non-Insulin-Dependent, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Coprosterol

MeSH term MeSH ID Detail
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Cataract D002386 34 associated lipids
Alcoholism D000437 27 associated lipids
Xanthomatosis D014973 17 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Biliary Fistula D001658 13 associated lipids
Brain Diseases, Metabolic D001928 9 associated lipids
Total 9

PubChem Associated disorders and diseases

What pathways are associated with Coprosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Coprosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Coprosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Coprosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Coprosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Coprosterol?

Rodent Model

Rodent Model are used in the study 'Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.' (Keller RK et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Coprosterol

Download all related citations
Per page 10 20 50 100 | Total 485
Authors Title Published Journal PubMed Link
Tészás A et al. Presenile cataract: consider cholestanol. 2006 Arch. Ophthalmol. pmid:17030721
Stine KJ et al. Interaction of the glycoalkaloid tomatine with DMPC and sterol monolayers studied by surface pressure measurements and Brewster angle microscopy. 2006 J Phys Chem B pmid:17078662
Li D et al. Application of nonylphenol and coprostanol to identification of industrial and fecal pollution in Korea. 2007 Mar. Pollut. Bull. pmid:17097116
Miettinen TA and Gylling H Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. 2007 Clin. Chim. Acta pmid:17258182
Panzenboeck U et al. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. 2007 J. Lipid Res. pmid:17325385
Hashimoto N et al. Potato pulps lowered the serum cholesterol and triglyceride levels in rats. 2006 J. Nutr. Sci. Vitaminol. pmid:17330508
Lee SP et al. Biliary sludge as a cause of acute pancreatitis. 1992 N. Engl. J. Med. pmid:1734248
Steinberg WM Acute pancreatitis--never leave a stone unturned. 1992 N. Engl. J. Med. pmid:1734255
Blokland MH et al. Development of a method which discriminates between endogenous and exogenous beta-boldenone. 2007 Anal. Chim. Acta pmid:17386706
Márk L and Paragh G [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption]. 2007 Orv Hetil pmid:17403635
Shah VG et al. Comparisons of water quality parameters from diverse catchments during dry periods and following rain events. 2007 Water Res. pmid:17428519
Shah VG et al. Bacterial source tracking from diverse land use catchments by sterol ratios. 2007 Water Res. pmid:17433407
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Ratajczak MK et al. Cholesterol displacement from membrane phospholipids by hexadecanol. 2007 Biophys. J. pmid:17526582
Lancelot E and Grauby-Heywang C Comparison of the interaction of dihydrocholesterol and cholesterol with sphingolipid or phospholipid Langmuir monolayers. 2007 Colloids Surf B Biointerfaces pmid:17544260
Szalat A et al. Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment. 2007 Biochim. Biophys. Acta pmid:17553741
Burghaus L et al. [Cerebrotendinous xanthomatosis]. 2007 Dtsch. Med. Wochenschr. pmid:17583829
Tyagi P et al. Use of selected chemical markers in combination with a multiple regression model to assess the contribution of domesticated animal sources of fecal pollution in the environment. 2007 Chemosphere pmid:17590407
Shah VG et al. Evaluating potential applications of faecal sterols in distinguishing sources of faecal contamination from mixed faecal samples. 2007 Water Res. pmid:17614115
Poerschmann J et al. Investigation of the solvent extracts of humic organic matter (HOM) isolated from the Ravenna Lagoon to study environmental pollution and microbial communities. 2007 Chemosphere pmid:17663998